Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Rafati

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Veterinary Microbiology|December 13, 2016
Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c MiceMaryam Golshani, Sima Rafati, Mehdi Nejati-Moheimani, et al.
Protein and Peptide Letters|July 16, 2009
Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c miceArash Memarnejadian, Farzin Roohvand, Arash Arashkia, et al.
Experimental Parasitology|December 21, 2007
Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c miceSima Rafati, Farnaz Zahedifard, Mahnaz Kakeh Azari, et al.
Applied Microbiology and Biotechnology|March 11, 2016
Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice modelMaryam Heidari-Kharaji, Tahereh Taheri, Delaram Doroud, et al.
Virus Genes|November 3, 2009
Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c miceArash Arashkia, Farzin Roohvand, Arash Memarnejadian, et al.
Parasites & Vectors|October 19, 2022
Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasisMahya Sadat Lajevardi, Tahereh Taheri, Elham Gholami, et al.
The Journal of Clinical and Aesthetic Dermatology|July 15, 2024
A Case Series of 36 Patients Treated for Old World Cutaneous leishmaniasisZahra Saffarian, Zahra Vasfi Marandi, Safoura Shakoei, et al.
Applied Biochemistry and Biotechnology|October 18, 2025
A Chimeric Peptide-Carbon Quantum Dot Nanobiohybrid System for Gene Delivery to Macrophage CellsMarziyeh Mousazadeh, Maryam Nikkhah, Sajad Moradi, et al.
Clinical and Vaccine Immunology : CVI|October 10, 2006
Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasisSima Rafati, Nafiseh Hassani, Yasaman Taslimi, et al.
Drug Design, Development and Therapy|August 9, 2020
A Synthetic Peptide 2Abz<sup>23</sup>S<sup>29</sup> Reduces Bacterial Titer and Induces Pro-Inflammatory Cytokines in a Murine Model of Urinary Tract InfectionNeda Moazzezy, Mohammad Reza Asadi Karam, Sima Rafati, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Veterinary Microbiology|December 13, 2016
Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c MiceMaryam Golshani, Sima Rafati, Mehdi Nejati-Moheimani, et al.
Protein and Peptide Letters|July 16, 2009
Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB/c miceArash Memarnejadian, Farzin Roohvand, Arash Arashkia, et al.
Experimental Parasitology|December 21, 2007
Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c miceSima Rafati, Farnaz Zahedifard, Mahnaz Kakeh Azari, et al.
Applied Microbiology and Biotechnology|March 11, 2016
Solid lipid nanoparticle loaded with paromomycin: in vivo efficacy against Leishmania tropica infection in BALB/c mice modelMaryam Heidari-Kharaji, Tahereh Taheri, Delaram Doroud, et al.
Virus Genes|November 3, 2009
Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c miceArash Arashkia, Farzin Roohvand, Arash Memarnejadian, et al.
Parasites & Vectors|October 19, 2022
Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasisMahya Sadat Lajevardi, Tahereh Taheri, Elham Gholami, et al.
The Journal of Clinical and Aesthetic Dermatology|July 15, 2024
A Case Series of 36 Patients Treated for Old World Cutaneous leishmaniasisZahra Saffarian, Zahra Vasfi Marandi, Safoura Shakoei, et al.
Applied Biochemistry and Biotechnology|October 18, 2025
A Chimeric Peptide-Carbon Quantum Dot Nanobiohybrid System for Gene Delivery to Macrophage CellsMarziyeh Mousazadeh, Maryam Nikkhah, Sajad Moradi, et al.
Clinical and Vaccine Immunology : CVI|October 10, 2006
Amastin peptide-binding antibodies as biomarkers of active human visceral leishmaniasisSima Rafati, Nafiseh Hassani, Yasaman Taslimi, et al.
Drug Design, Development and Therapy|August 9, 2020
A Synthetic Peptide 2Abz<sup>23</sup>S<sup>29</sup> Reduces Bacterial Titer and Induces Pro-Inflammatory Cytokines in a Murine Model of Urinary Tract InfectionNeda Moazzezy, Mohammad Reza Asadi Karam, Sima Rafati, et al.
Pageof 14